Carol Burke, M.D.

Carol Burke, MD, completed medical school at the Ohio State University College of Medicine and Public Health, and residency at Riverside Methodist Hospital, both in Columbus, Ohio. Dr. Burke performed her Gastroenterology Fellowship at the Cleveland Clinic in 1993 and has been on the professional staff since that time.

Dr. Burke enjoys patient care, medical education and research, particularly in the area of colorectal polyp and cancer prevention. She is internationally known for her work in the polyposis syndromes and is the Director of the Center for colon polyp and cancer prevention and has been awarded research grants from the National Cancer Institute, American College of Gastroenterology, and Industry to name a few,  to study the effects of chemopreventive agents on the prevention of intestinal neoplasia.

She is the co-director of the multi-disciplinary Hereditary Cancer Clinic and provides consultations including risk assessment, and endoscopic evaluation and treatment for individuals with a hereditary predisposition to cancer.

She is the author of numerous peer reviewed manuscripts, abstracts, book chapters, and is a frequent reviewer for many digestive disease journals.

She has served as a committee member, or chairperson in the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy and is currently on the Board of Trustees for the American College of Gastroenterology.

• Associate Editor for the American Journal of Gastroenterology
• Reviewer for the journals: Gastroenterology, Clinical Gastroenterology and Hepatology, Diseases of the Colon and Rectum, Gastrointestinal Endoscopy, Archives of Internal Medicine

Colonic neoplasia, hereditary polyposis and nonpolyposis colorectal cancer, colorectal cancer screening strategies, chemoprevention of colorectal neoplasia.

Dr. Burke is on the Board of Trustees of the American College of Gastroenterology.

Dr. Burke is a member of the National Medical Honor Society, Alpha Omega Alpha

• Fellow, American College of Gastroenterology
• Fellow, American College of Physicians
• Member, American Society of Gastrointestinal Endoscopy
• Member, American Gastroenterologic Association
• Member, International Society on Inherited Gastrointestinal Hereditary Tumors

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Burke has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Burke receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

• Takeda

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)